Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Unavailable
    Monoclonal Antibodies: Meeting the Challenges in Manufacturing, Formulation, Delivery and Stability of Final Drug Product
    Unavailable
    Monoclonal Antibodies: Meeting the Challenges in Manufacturing, Formulation, Delivery and Stability of Final Drug Product
    Unavailable
    Monoclonal Antibodies: Meeting the Challenges in Manufacturing, Formulation, Delivery and Stability of Final Drug Product
    Ebook470 pages5 hours

    Monoclonal Antibodies: Meeting the Challenges in Manufacturing, Formulation, Delivery and Stability of Final Drug Product

    By Steven Shire

    ()

    Currently unavailable

    Currently unavailable

    About this ebook

    Monoclonal antibodies (MAbs) are currently the major class of protein bio therapeutic being developed by biotechnology and pharmaceutical companies. Monoclonal Antibodies discusses the challenges and issues revolving around development of a monoclonal antibody produced by recombinant DNA technology into a therapeutic agent.This book covers downstream processing which includes design of processes to manufacture the formulation, formulation design, fill and finish into closure systems and routes of administration. The characterization of the final drug product is covered where the use of biophysical methods combined with genetic engineering is used to understand the solution properties of the formulation. The latter has become very important since many indications such as arthritis and asthma require the development of formulations for subcutaneous delivery (SC). The development of formulations for IV delivery is also important and comes with a different set of challenges. The challenges and strategies that can overcome these limitations are discussed in this book, starting with an introduction to these issues, followed by chapters detailing strategies to deal with them. Subsequent chapters explore the processing and storage of mAbs, development of delivery device technologies and conclude with a chapter on the future of mAbs in therapeutic remedies.

    • Discusses the challenges to develop MAbs for intravenous (IV) and subcutaneous delivery (SC)
    • Presents strategies to meet the challenges in development of MAbs for SC and IV administration
    • Discusses the use of biophysical analytical tools coupled with MAb engineering to understand what governs MAb properties at high concentration
    LanguageEnglish
    PublisherElsevier Science
    Release dateApr 24, 2015
    ISBN9780081002971
    Unavailable
    Monoclonal Antibodies: Meeting the Challenges in Manufacturing, Formulation, Delivery and Stability of Final Drug Product
    Author

    Steven Shire

    Steven J. Shire is currently consulting and serving as an adjunct faculty member of the USC School of Pharmacy and University of Connecticut School of Pharmaceutical Sciences. He was at Genentech for 32 years where the majority of his career was in the pharmaceutical development department. He retired in June 2013 as Staff Scientist in the Late Stage Pharmaceutical Development Department. He has been responsible for directing research and development of formulations for a variety of recombinant human proteins including Pulmozyme® and Xolair®. Dr. Shire has served as the chair of the American Association of Pharmaceutical Scientists (AAPS) Biotechnology Section, and was elected as a Fellow of AAPS in 1998 and member at large to the AAPS Executive Council in 2001. He has published over 80 reviews and papers dealing with various aspects of formulation and pharmaceutical development of therapeutic proteins.

    Related to Monoclonal Antibodies

    Related ebooks

    Medical For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Remember, Remember The 2020 November

      Jan 7, 2021

      World-changing innovations are like London buses: you wait for years and then three come along at once. The recent wait has been particularly irksome, as virology and epidemiology felt like the only relevant sciences in lockdown – apart from rocket s

      3 min read

    • Article

      Nanomaterial Found To Reduce Cancer Stem Cells In Rats, Chinese Study Finds

      Sep 28, 2022

      Chinese scientists say they have developed a smart nanomaterial that significantly reduced the number of cancer stem cells in rats in a recent study. Therapies that can selectively eliminate cancer cells mean less damage to a patient's healthy cells.

      2 min read

    • Article

      Opinion: Companies Must Responsibly Manufacture The Antimicrobials Society Needs

      Jan 30, 2020

      Providing access to antibiotics and other antimicrobials while reducing resistance to these medicines presents a dual manufacturing challenge: ensuring a cost-effective supply while minimizing their emission into the environment.

      4 min read

    • Article

      The Serious Risks Around Treatment of Biomethane in 45V

      Feb 2, 2024

      "Clean hydrogen" production tax credits in the Inflation Reduction Act must be further defined and limited, or they risk allowing for more climate- and health-damaging emissions.

      6 min read

    • Article

      Loop The Loop

      Oct 1, 2021

      Loop The Loop
      5 min read

    • Article

      How Reliable Are Gas Power Plants? What ICAP, UCAP, and ELCC Tell Us.

      Aug 23, 2023

      With climate change leading to increasingly extreme weather events that strain the power grid, it is critical to get capacity accreditation right to ensure that we have enough resources to keep the lights on.

      7 min read

    • Article

      Current Trends

      Oct 1, 2021

      It won’t be news to you that there is a lot of development work going on in the world of cell technology for traction batteries. The current trend with cell chemistries is for the high capacity cells to become higher capacity at the sacrifice of peak

      3 min read

    • Article

      Root Propagation and Powdery Mildew

      Mar 10, 2023

      What are the effects of antimicrobial solutions on cannabis cultivation and production? The cannabis industry is growing at an explosive rate and the regulations governing the cultivation, processing, and distribution are rapidly evolving. They’re al

      4 min read

    • Article

      System Could Make Seawater Drinkable

      Jan 24, 2024

      Researchers have achieved a major breakthrough in redox flow desalination, an emerging electrochemical technique that can turn seawater into potable drinking water and also store affordable renewable energy. In a paper published in Cell Reports Physi

      2 min read

    • Article

      The Second-Life of Used EV Batteries

      May 27, 2020

      The Second-Life of Used EV Batteries
      6 min read

    • Article

      Management Structure

      Nov 4, 2022

      Management Structure
      9 min read

    • Article

      Technologue

      Dec 27, 2019

      Remember the Lamborghini Terzo Millennio concept, launched in November 2017? This wild design study showed Lamborghini’s impression of what a fully electric future hypercar might look like. The design was launched at the same time the company publici

      2 min read

    • Article

      Laboratory Test Report

      Mar 28, 2022

      Laboratory Test Report
      1 min read

    • Article

      £10k Charity Target For Accurascale Exclusive ‘Shed’

      Aug 29, 2023

      MODERN image modellers will be able to support charity when purchasing a special edition Class 66 model directly from Accurascale. Adopting the nickname from their garden shed-style cab roof, Class 66 No. 66769 in GBRf Prostate Cancer UK livery was l

      2 min read

    Related categories

    Reviews for Monoclonal Antibodies

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words